
Open Source Drug Discovery is a Council of Scientific and Industrial Research, India-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Open Source Drug Discovery, India, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
56%
Total
Publications
129
Total Open
Publications
72
Total
Citations
2.1K
Open Access
Percentage
56%
Total
Publications
129
Total Open
Publications
72
Total
Citations
2.1K
Breakdown
Publisher Open
21%
Both
31%
Other Platform Open
2%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 51%
33
Hybrid 25%
16
No Guarantees 24%
16
Other Platform Open
Domain 65%
28
Other Internet 26%
11
Institution 21%
9
Public 9%
4
Preprint 5%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 28 |
DOI | Other Internet | 11 |
Europe PMC | Domain | 10 |
Figshare | Public | 4 |
University of Denver | Institution | 2 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 2 |
University of Oxford | Institution | 1 |
Swissuniversities | Institution | 1 |
Preprints | Preprint | 1 |
Office of Scientific and Technical Information | Institution | 1 |